CYCC
Cyclacel Pharmaceuticals Inc
NASDAQ: CYCC · HEALTHCARE · BIOTECHNOLOGY
$6.37
+0.00% today
Updated 2026-04-29
Market cap
$14.25M
P/E ratio
0.00
P/S ratio
1,425.11x
EPS (TTM)
$7,123.50
Dividend yield
—
52W range
$3 – $98
Volume
—
Cyclacel Pharmaceuticals Inc (CYCC) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
—
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|